Compare GEL & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEL | LMAT |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 1996 | 2006 |
| Metric | GEL | LMAT |
|---|---|---|
| Price | $15.63 | $94.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $19.50 | ★ $105.80 |
| AVG Volume (30 Days) | 247.5K | ★ 252.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.19% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | ★ $2,912,770,000.00 | $249,602,000.00 |
| Revenue This Year | $12.12 | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ N/A | $137.59 |
| Revenue Growth | ★ 43.60 | 13.53 |
| 52 Week Low | $14.55 | $79.01 |
| 52 Week High | $18.64 | $118.01 |
| Indicator | GEL | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 36.34 |
| Support Level | $14.92 | $82.26 |
| Resistance Level | $16.44 | $114.38 |
| Average True Range (ATR) | 0.46 | 2.92 |
| MACD | 0.02 | -0.20 |
| Stochastic Oscillator | 44.17 | 28.84 |
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.